A researcher has tested a DNA vaccine's potential for treating melanomas, common in gray horses, with encouraging results: safety and immune response against the tumor component tyrosinase.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In